Description
A potent inhibitor of Cdk1, Cdk2, and Cdk9 (IC50s = 16, 6, and 20 nM, respectively); inhibits kinase activity of Cdk5/p25 and GSK3β; induces cell cycle arrest by inhibiting phosphorylation of CDK-dependent substrates; has in vivo antiproliferative activity against a range of tumor cell lines (IC50s ranging from 200-1,700 nM); in vivo oral administration inhibits growth of human tumor xenografts and inhibits cell cycle proteins
Formal name: 4-[2-methyl-1-(1-methylethyl)-1H-imidazol-5-yl]-N-[4-(methylsulfonyl)phenyl]-2-pyrimidinamine
Synonyms:
Molecular weight: 371.5
CAS: 602306-29-6
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Kinase Inhibitors|CDKs||Product Type|Biochemicals|Kinase Inhibitors|GSK3||Product Type|Biochemicals|Small Molecule Inhibitors|Kinases||Research Area|Cancer|Cell Cycle||Research Area|Cancer|Cell Signaling|GSK3 Signaling